Broad Institute
Broad Institute, Collaborators Eye CRISPR Panel to Detect SARS-CoV-2 Variants, Respiratory Viruses
Premium
The group has developed a panel to detect SARS-CoV-2, other coronaviruses, and influenza A and B that also identified and differentiated six variant lineages.
Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm
Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs.
The point-of-care system can detect SARS-CoV-2 in unprocessed patient saliva in about an hour, according to the researchers.
ACMG Presentation Highlights Broad Institute's Massive Expansion of COVID-19 Testing Program
The Broad's clinical research sequencing lab now runs 135,000 tests each day and routinely tests more than 100 higher education sites and 40 schools in the state.
FDA Grants EUA for Use of Broad Institute Coronavirus PCR Test With Self-Collected Samples
The test, which detects the SARS-CoV-2 N gene, was previously granted Emergency Use Authorization for use with samples collected by a healthcare provider.